[Clinico-physiologic effect of glucagon in patients after surgery for tumors of the sellar-diencephalic area].
D000328:Adult; D001932:Brain Neoplasms / Q000601:surgery*; D003072:Cognition Disorders / Q000188:drug therapy*; D003244:Consciousness Disorders / Q000188:drug therapy*; D003397:Craniopharyngioma / Q000601:surgery; D004027:Diencephalon; D004569:Electroencephalography; D004734:Energy Metabolism; D005934:Glucagon / Q000627:therapeutic use*; D006801:Humans; D008577:Meningeal Neoplasms / Q000601:surgery*; D008579:Meningioma / Q000601:surgery; D008659:Metabolic Diseases / Q000188:drug therapy; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000601:surgery*; D011183:Postoperative Complications / Q000188:drug therapy; D012658:Sella Turcica
D005934:Glucagon
Kliniko-fiziologicheskiĭ éffekt gliukagona u bol'nykh, operirovannykh po povodu opukholeĭ selliarno-diéntsefal'noĭ oblasti.